Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Director | $15M | -$5.87M | -28.1% | Sep 24, 2024 |
ABUS | Arbutus Biopharma Corp | Director | $170K | -$32.6K | -16.1% | Aug 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|